Evosep Biosystems

📍 Odense C, Denmark🗓 Founded 2016👥 79 employees💰 Last funded Jan 2023
Biotechnology Research🌐 evosep.com
Website LinkedIn
Evosep develops new solutions to make clinical proteomics 100 times more robust and 10 times faster. We are targeting the growing need for throughput with robust solutions for clinical and large-scale proteomics, and we have a very ambitious business plan to bring the community closer to the clinic. We are basing our design on years of experience with nano-UHPLC R&D and application support, critically rethinking the necessary system architectures for successful sample separation before mass spectrometric analysis.
2
Total investors
1
Early stage
0
Mid stage
1
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Denmark
1
Frequently asked questions
Who invested in Evosep Biosystems?
Evosep Biosystems has 2 investors on record on gritt.io, including 1 early-stage backers and 1 late-stage investors.
When did Evosep Biosystems last raise funding?
The most recent investment in Evosep Biosystems recorded on gritt.io was in January 2023.
When was Evosep Biosystems founded?
Evosep Biosystems was founded in 2016.
What industry is Evosep Biosystems in?
Evosep Biosystems operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Evosep Biosystems based?
Evosep Biosystems is headquartered in Odense C, Denmark.